This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Fondation Asile Des Aveugles. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yvan Arsenijevic: Innovator in Eye Disorder Treatments
Introduction
Yvan Arsenijevic is an inventor based in Lausanne, Switzerland. He is currently associated with the Fondation Asile Des Aveugles. Although he has not yet been granted any patents, his work focuses on innovative solutions for treating eye disorders.
Latest Patent Applications
Yvan Arsenijevic's notable patent application is titled "Inhibition of PRC2 Subunits to Treat Eye Disorders." This application presents inhibitors of one or more subunits of polycomb repressive complex 2 (PRC2) for use in the prevention or treatment of eye disorders. The methods described aim to address non-cancer disorders characterized by degeneration or cell death of retinal neurons. Specifically, the application discusses the use of inhibitors targeting the subunits EZH1 or EZH2, which are involved in H3K27 trimethylation.
Conclusion
Yvan Arsenijevic is making strides in the field of eye disorder treatments through his innovative research and patent applications. His contributions may pave the way for new therapeutic approaches in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile